Pursuits
Gilead Subpoenaed as Feds Probe Drugmaker-Charity Connections
- Biogen and Jazz report subpoenas as investigation widens
- Fueled by pharma-industry gifts, charities’ coffers doubled
This article is for subscribers only.
Three drugmakers have disclosed receiving subpoenas amid a widening federal investigation into pharmaceutical companies’ relationships with charities that help people afford their products.
Gilead Sciences Inc., Biogen Inc. and Jazz Pharmaceuticals Plc said they’ve received subpoenas this year for documents related to such nonprofits, though the companies provided few additional details. Two companies, Gilead and Jazz, said their subpoenas came from the U.S. Attorney for the District of Massachusetts. The filings didn’t disclose names of specific charities.